Safety considerations for IMRT: Executive summary.
Safety considerations for IMRT: Executive summary.
复制标题
DOI：
10.1016/j.prro.2011.04.008
复制
发表时间：
2011-07
影响因子：
3.3
通讯作者：
Marks LB
中科院分区：
文献类型：
--
作者：
Moran JM;Dempsey M;Eisbruch A;Fraass BA;Galvin JM;Ibbott GS;Marks LB
这份关于调强放射治疗(IMRT)的报告是美国放射肿瘤学会(ASTRO)目标安全运动委托编写的一系列关于患者安全的白皮书的一部分。该文件已得到应科院董事会的批准，得到美国医学物理学家协会(AAPM)和美国医学剂量师协会(AAMD)的认可，并得到美国放射学会放射肿瘤学委员会的审查和接受。本报告涉及应科院病人安全白皮书系列的其他报告，这些报告仍在编写中，在适当的情况下，它将遵循这些小组将在未来白皮书中发表的指导意见。本文件尽可能利用放射肿瘤学中关于质量保证和质量控制原则的大量工作。调强放射治疗提高了使等剂量分布符合靶体形状的能力(S)，从而减少了对一些邻近关键结构的剂量。调强放射治疗的这种前景是其广泛使用的原因之一。然而，调强放射治疗的前景被调强放射治疗计划和交付过程的复杂性以及相关风险所抵消，其中一些风险已被《纽约时报》关于涉及调强放射治疗和其他放射治疗方式的严重事故的报道所证明。本报告提供了一个广泛讨论IMRT安全交付的机会，主要侧重于预防人为错误的建议和减少可能导致灾难性故障或错误的机器故障的发生的方法。
This report on intensity‐modulated radiation therapy (IMRT) is part of a series of white papers addressing patient safety commissioned by the American Society for Radiation Oncology's (ASTRO) Target Safely Campaign. The document has been approved by the ASTRO Board of Directors, endorsed by the American Association of Physicists in Medicine (AAPM) and American Association of Medical Dosimetrists (AAMD), and reviewed and accepted by the American College of Radiology's Commission on Radiation Oncology. This report is related to other reports of the ASTRO white paper series on patient safety which are still in preparation, and when appropriate it defers to guidance that will be published by those groups in future white papers. This document takes advantage of the large body of work on quality assurance and quality control principles within radiation oncology whenever possible. IMRT provides increased capability to conform isodose distributions to the shape of the target(s), thereby reducing dose to some adjacent critical structures. This promise of IMRT is one of the reasons for its widespread use. However, the promise of IMRT is counterbalanced by the complexity of the IMRT planning and delivery processes, and the associated risks, some of which have been demonstrated by the New York Times reports on serious accidents involving both IMRT and other radiation treatment modalities. This report provides an opportunity to broadly address safe delivery of IMRT, with a primary focus on recommendations for human error prevention and methods to reduce the occurrence of errors or machine malfunctions that can lead to catastrophic failures or errors.